Deaths from second trimester abortion by dilatation and evacuation: causes, prevention, facilities.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 7279335)

Published in Obstet Gynecol on October 01, 1981

Authors

W Cates, D A Grimes

Articles citing this

First trimester fetal diagnosis of genetic disorders: clinical evaluation of 250 cases. J Med Genet (1985) 0.84

International developments in abortion laws: 1977-88. Am J Public Health (1988) 0.81

Abortion alarums. Am J Public Health (1982) 0.75

Articles by these authors

Sexual transmission of HIV. N Engl J Med (1997) 6.84

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA (1994) 5.80

Septic abortion. N Engl J Med (1994) 3.90

Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol (1989) 3.24

Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect (2008) 3.19

Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation. Lancet (1999) 2.99

Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ (1996) 2.99

Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev (2007) 2.86

Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. Genitourin Med (1987) 2.77

Gonorrhea rates: what denominator is most appropriate? Am J Public Health (1988) 2.72

The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis (1997) 2.70

Congenital syphilis revisited. Am J Dis Child (1985) 2.50

HIV counseling and testing: does it work? Am J Public Health (1988) 2.47

Rapid assessment of health status and preventive-medicine needs of newly arrived Kampuchean refugees, Sa Kaeo, Thailand. Lancet (1980) 2.34

Personal protection against sexually transmitted diseases. Am J Obstet Gynecol (1986) 2.34

The increasing concern with infertility. Why now? JAMA (1983) 2.24

Worldwide patterns of infertility: is Africa different? Lancet (1985) 2.15

From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect (2008) 2.09

Mid-trimester abortion by dilatation and evacuation: a safe and practical alternative. N Engl J Med (1977) 2.04

Deaths from paracervical anesthesia used for first-trimester abortion, 1972-1975. N Engl J Med (1976) 1.95

The validity of the postcoital test. Am J Obstet Gynecol (1990) 1.92

Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol (1993) 1.92

Causes of maternal mortality in the United States. Obstet Gynecol (1985) 1.91

Perinatal and maternal mortality in a religious group avoiding obstetric care. Am J Obstet Gynecol (1984) 1.88

Complications from legally-induced abortion: a review. Obstet Gynecol Surv (1979) 1.85

Restricting medicaid funds for abortions: projections of excess mortality for women for childbearing age. Am J Public Health (1977) 1.78

Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA (2001) 1.76

Primary prevention of sexually transmitted diseases. A primer for clinicians. JAMA (1986) 1.75

Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev (2005) 1.75

Contraception's proved potential to fight HIV. Sex Transm Infect (2005) 1.75

1. The effect of delay and method choice on the risk of abortion morbidity. Fam Plann Perspect (1978) 1.74

Rh immunoglobulin utlization after spontaneous and induced abortion. Obstet Gynecol (1977) 1.67

Race-specific patterns of abortion use by American teenagers. Am J Public Health (1982) 1.63

Epidemiology of ectopic pregnancy. Epidemiol Rev (1987) 1.62

Vaginal douching among women of reproductive age in the United States: 1988. Am J Public Health (1992) 1.60

Preventing neonatal herpes. The value of weekly viral cultures in pregnant women with recurrent genital herpes. JAMA (1984) 1.59

Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol (1996) 1.59

The impact of state maternal mortality study committees on maternal deaths in the United States. Am J Public Health (1977) 1.58

Preventing pelvic inflammatory disease. JAMA (1991) 1.56

Self-reported pelvic inflammatory disease in the United States, 1988. JAMA (1991) 1.54

The risks associated with teenage abortion. N Engl J Med (1983) 1.53

Contraception and ectopic pregnancy risk. Am J Obstet Gynecol (1990) 1.51

Genital Chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health (1997) 1.50

A randomized clinical trial comparing Pipelle and Tis-u-trap for endometrial biopsy. Obstet Gynecol (1990) 1.50

Legal abortion mortality in the United States. Epidemiologic surveillance, 1972-1974. JAMA (1977) 1.49

Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol (1995) 1.48

Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev (2008) 1.47

Sexually transmitted diseases and family planning. Strange or natural bedfellows, revisited. Sex Transm Dis (1993) 1.44

Diagnostic dilation and curettage: a reappraisal. Am J Obstet Gynecol (1982) 1.43

Standardized mortality rates associated with legal abortion: United States, 1972-1975. Fam Plann Perspect (1978) 1.43

Cervical cap versus diaphragm for contraception. Cochrane Database Syst Rev (2002) 1.43

Illegal abortions in the united states: 1972-1974. Fam Plann Perspect (1976) 1.43

The sperm penetration assay: can it discriminate between fertile and infertile men? Am J Obstet Gynecol (1988) 1.42

The intrauterine device and deaths from spontaneous abortion. N Engl J Med (1976) 1.42

Luteal phase deficiency: effect of treatment on pregnancy rates. Am J Obstet Gynecol (1992) 1.40

Immunization as therapy for recurrent spontaneous abortion: a review and meta-analysis. Obstet Gynecol (1993) 1.38

Surgical management of leiomyomata during pregnancy. Obstet Gynecol (1989) 1.38

Trends in national abortion mortality, United States, 1940-1974: implications for prevention of future abortion deaths. Adv Plan Parent (1976) 1.38

Stress, work, and pregnancy complications. Epidemiology (1996) 1.37

Clinical teaching reexamined. J Med Educ (1975) 1.37

The effectiveness of barrier methods of contraception in preventing the spread of HIV. AIDS (1995) 1.36

Alternate testing sites for AIDS virus. Am J Public Health (1987) 1.33

Hospitalizations for pelvic inflammatory disease. Epidemiology and trends in the United States, 1975 to 1981. JAMA (1984) 1.32

Mifepristone (RU 486)--an abortifacient to prevent abortion? N Engl J Med (1992) 1.30

Partner notification for the prevention of HIV infection. AIDS (1989) 1.29

The effects of induced abortion on subsequent reproduction. Epidemiol Rev (1982) 1.28

The health impact of restricting public funds for abortion. October 10, 1977--June 10, 1978. Am J Public Health (1979) 1.27

Overview: individual and population approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection. J Infect Dis (1996) 1.25

Sexually transmitted organisms and infertility: the proof of the pudding. Sex Transm Dis (1984) 1.25

Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol (1984) 1.25

Assessing risk for pelvic inflammatory disease and its sequelae. JAMA (1991) 1.24

Congenital syphilis. Why is it still occurring? JAMA (1984) 1.24

Self-reported pelvic inflammatory disease in the US: a common occurrence. Am J Public Health (1985) 1.23

Ectopic pregnancy in the United States 1970 through 1978. JAMA (1983) 1.23

Response of low income women and abortion facilities to restriction of public funds for abortion: a study of a large metropolitan area. Am J Public Health (1979) 1.22

Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev (2007) 1.18

Adolescents and sexually transmitted diseases: an expanding problem. Introduction. J Adolesc Health Care (1985) 1.17

Prevention of uterine perforation during curettage abortion. JAMA (1984) 1.17

Legal abortion: the public health record. Science (1982) 1.15

Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev (2006) 1.14

Condoms and urinary tract infections: is nonoxynol-9 the problem or the solution? Epidemiology (1997) 1.13

Deaths due to sexually transmitted diseases. The forgotten component of reproductive mortality. JAMA (1986) 1.12

The real problem with male condoms is nonuse. Sex Transm Dis (1999) 1.11

A guide to interpreting contraceptive efficacy studies. Obstet Gynecol (1990) 1.09

Assessment of surveillance and vital statistics data for monitoring abortion mortality, United States, 1972-1975. Am J Epidemiol (1978) 1.07

New technologies in cervical cytology screening: a word of caution. Obstet Gynecol (1999) 1.07

Local versus general anesthesia: which is safer for performing suction curettage abortions? Am J Obstet Gynecol (1979) 1.07

Progestins, breast cancer, and the limitations of epidemiology. Fertil Steril (1992) 1.07

Measures to prevent cervical injury during suction curettage abortion. Lancet (1983) 1.07

Contraceptive failure in the United States: an update. Stud Fam Plann (1990) 1.07

Women refused second-trimester abortion: correlates of pregnancy outcome. Am J Obstet Gynecol (1983) 1.05